BioPharma Reporter

FEBRUARY 22, 2024

MIP Discovery, a developer of non-biological affinity reagents designed to accelerate the production of cell and gene therapies, has closed a Â7 million Series A financing round, led by Mercia Ventures.

Gene 97

Gene Reagent Gene Therapy Production 97

Drug Discovery World

MAY 7, 2024

Where the bottlenecks of achieving higher cell density and higher titers were once thought to be issues of the past, hurdles have now shifted to achieving speed and scale in mAb production without sacrificing quality. DC: Antibodies have and remain a large product class within the biopharmaceutical market.

Antibody 59

Antibody Production Manufacturing Engineer 59

BioTech 365

SEPTEMBER 8, 2020

$599.00End Date: Thursday Oct-8-2020 10:58:07 PDTBuy It Now for only: $599.00Buy It Now | Add to watch list Biotech365 : BioTek™ MicroFill® Microplate Dispenser AF1000A 96/384 Well Reagent u Fill BioMarketplace You want to propose your products or a Biotech … Continue reading →

Reagent 40

Reagent Production 40

Drug Discovery World

FEBRUARY 21, 2024

MIP Discovery’s non-biological affinity reagents support a new approach to viral vector characterisation, viral vector purification, and safety and QC processes, such as the detection and removal of impurities. The funds will also support recruitment efforts to expand in-house CGT expertise.

Gene Therapy 52

Gene Therapy Gene Reagent Production 52

BioPharma Reporter

JULY 5, 2021

Sartorius is strengthening its product portfolio for cell and gene therapies with the acquisition of a majority stake in German reagent manufacturer CellGenix.

Reagent 90

Reagent Gene Therapy Gene Manufacturing 90

Drug Discovery World

SEPTEMBER 17, 2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Register for free now to secure your place.

Reagent 52

Reagent In-Vitro Life Science Scientist 52

FDA Law Blog

SEPTEMBER 11, 2024

For example, depending on the manufacturing process for a specific human drug, the use of some specific solvents, reagents, and catalysts may trigger the formation of these possible carcinogens. First, firms should undertake risk assessments of their APIs, finished products, and products under approved or pending applications.

Bioequivalency 105

Bioequivalency Manufacturing Reagent Production 105

Drug Discovery World

AUGUST 11, 2023

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. GenScript will provide various CRISPR reagents to support the development of the universal CAR-T products from discovery to commercialisation.

Reagent 52

Reagent Development Gene Editing Production 52

Drug Discovery World

OCTOBER 3, 2022

Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. The post Video: Where chemistry meets biology and products meet services appeared first on Drug Discovery World (DDW).

Production 52

Production Life Science Manufacturing Research 52

Drug Discovery World

SEPTEMBER 10, 2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Register for free now to secure your place.

Reagent 52

Reagent In-Vitro Life Science Scientist 52

Roots Analysis

AUGUST 29, 2023

Cell therapy consumables are materials which are used in the manufacturing of cell therapies, however, do not form a part of the final product. Raw materials used for the production of cell therapies include culture media, growth factors, extracellular matrices and reagents.

Reagent 52

Reagent Manufacturing Production Containment 52

Drug Discovery World

OCTOBER 1, 2022

Securing life sciences supply chains – where chemistry meets biology and products meet services. Biosynth is at the edge of innovation.

Reagent 52

Reagent Life Science Manufacturing Production 52

Drug Discovery World

SEPTEMBER 3, 2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Register for free now to secure your place.

In-Vitro 52

In-Vitro Reagent Life Science Scientist 52

FDA Law Blog

JANUARY 4, 2023

Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and contr­­ols (CMC).

Reagent 59

Reagent Manufacturing Production Gene Therapy 59

Drug Discovery World

AUGUST 27, 2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Register for free now to secure your place.

Reagent 52

Reagent In-Vitro Life Science Scientist 52

Drug Discovery World

AUGUST 20, 2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Register for free now to secure your place.

Reagent 52

Reagent In-Vitro Life Science Scientist 52

BioPharma Reporter

FEBRUARY 3, 2022

Polyplus, a provider of transfection reagents, has acquired e-Zyvec, a France-based provider of DNA design and production services for tailor-made DNA vectors to expand expertise in plasmid DNA vector engineering.

DNA 52

DNA Reagent Engineer Production 52

Pharmaceutical Technology

APRIL 3, 2023

The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. Polyplus, based in Strasbourg, France, produces key components in the production of viral vectors used in cell and gene therapies.

Gene Therapy 246

Gene Therapy Gene DNA Reagent 246

Drug Discovery World

MAY 2, 2023

The winners will receive a MagicPrep NGS instrument only, no reagents or consumables are included. Then submit an abstract today for your chance to win a MagicPrep NGS instrument* and enjoy NGS library preparation at the push of a button. For research use only. Not for use in diagnostic procedures. Submit your abstract.

Reagent 52

Reagent Research Production Drugs 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services.

Protein 130

Protein Marketing Manufacturing Reagent 130

BioTech 365

DECEMBER 15, 2021

Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of … Continue reading → Teknova to Join the Nasdaq Biotechnology Index Teknova to Join the Nasdaq Biotechnology Index HOLLISTER, Calif., 15, 2021 (GLOBE NEWSWIRE) — Alpha Teknova, Inc.

Reagent 40

Reagent Production Development 40

BioTech 365

NOVEMBER 16, 2021

Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of … Continue reading → Teknova to Participate in Upcoming Investor Conferences Teknova to Participate in Upcoming Investor Conferences HOLLISTER, Calif., 16, 2021 (GLOBE NEWSWIRE) — Alpha Teknova, Inc.

Reagent 40

Reagent Production Development 40

Drug Discovery World

SEPTEMBER 25, 2023

CRISPR gene editing companies Integrated DNA Technologies (IDT) and Aldevron have inked a new global distribution agreement to expand CRISPR products for cell and gene therapy customers.

Genome 52

Genome Genomics Gene Editing Medicine 52

BioTech 365

OCTOBER 8, 2021

Global Real Time PCR Market Research Report 2021 – ResearchAndMarkets.com Global Real Time PCR Market Research Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Real Time PCR Market, By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, (..)

Marketing 40

Marketing Reagent Research Production 40

BioTech 365

JULY 9, 2021

United States $30 Billion Diagnostics Market, Competition Forecast & Opportunities, 2026 – ResearchAndMarkets.com United States $30 Billion Diagnostics Market, Competition Forecast & Opportunities, 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “United States Diagnostics Market, By Product Type (Reagents, (..)

Marketing 40

Marketing Reagent Production 40

Drug Discovery World

SEPTEMBER 15, 2022

In the second article, Dr. Urmi Roy, Global Product Manager for Flow Cytometry Reagents, Miltenyi Biotec, explains why immunogenicity prediction is a key consideration for therapeutic development. In the first article, Marjie Hadad talks to cell therapy expert and Kadimastem CEO Asaf Shiloni about the potential of cell therapy.

Reagent 52

Reagent Production Drugs Development 52

Drug Discovery World

SEPTEMBER 15, 2022

In the second article, Dr. Urmi Roy, Global Product Manager for Flow Cytometry Reagents, Miltenyi Biotec, explains why immunogenicity prediction is a key consideration for therapeutic development. In the first article, Marjie Hadad talks to cell therapy expert and Kadimastem CEO Asaf Shiloni about the potential of cell therapy.

Reagent 52

Reagent Production Drugs Development 52

BioTech 365

FEBRUARY 15, 2021

Billion by 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Immunofluorescence Assay Market by Product (Reagent, Instruments, … Continue reading → The Worldwide Immunofluorescence Assay Industry is Expected to Reach $3.5

Reagent 40

Reagent Production Marketing 40

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

BioTech 365

SEPTEMBER 8, 2020

an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies, announced today key members of the leadership team hired to direct Invivoscribe Therapeutics, Inc., SAN DIEGO–(BUSINESS WIRE)–#invivoscribe–Invivoscribe, Inc.,

Reagent 52

Reagent Engineer Production Development 52

Pharmaceutical Technology

SEPTEMBER 1, 2022

In molecular devices, you have a lot of processes, and they are very complex because you are dealing with different reagents and with a variety of materials. To succeed, manufacturers must understand the technical challenges that come with devices this critical and sophisticated and ensure precision is built into their production processes.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

Drug Discovery World

SEPTEMBER 28, 2022

The grants will consist of $3,000 USD (or local currency equivalent) in genomics catalog products from Beckman Coulter Life Sciences. Winners will be evaluated based on criteria that include research objective, genomic reagent request, and how the product would be used in the field of research. .

Genome 52

Genome Genomics Research Life Science 52

Drug Discovery World

JANUARY 30, 2024

Pure materials All great products start with the best raw materials. Clean processes Great materials turn into great products when the cleanest and most precise production processes are used and are continuously monitored for quality. Every plate is made with the exact same formulation of resin, colourant and film.

Reagent 52

Reagent Contamination Production Drugs 52

Camargo

MAY 2, 2021

Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well as a new motivation for regulators to provide clear, efficient pathways for product developers. The meeting has several goals: Discuss issues critical to early product development.

Gene Therapy 155

Gene Therapy Gene Packaging Packaging 155

Roots Analysis

AUGUST 16, 2023

The success of COVID-19 vaccines paved the path for mRNA-based drug products. Safety, efficacy and rapid production of mRNA drives the interest in this domain. mRNA has completely revolutionized the field of medicine and significantly influenced the study and treatment of human diseases.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing RNA 52

Roots Analysis

FEBRUARY 21, 2022

However, the conventional nucleotide library preparation process has several challenges, including requirement of huge amount of starting materials, inadequate throughput and deteriorated quality of the product. Product Competitiveness Analysis. Next Generation Sequencing (NGS) Library Preparation Kits Market – Roots Analysis.

Marketing 52

Marketing Gene Sequencing DNA Genome 52